Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Mapping of conformational autoantibody epitopes in ZNT8.

Wenzlau JM, Frisch LM, Hutton JC, Davidson HW.

Diabetes Metab Res Rev. 2011 Nov;27(8):883-6. doi: 10.1002/dmrr.1266.

2.

ZnT8 and type 1 diabetes.

Kawasaki E.

Endocr J. 2012;59(7):531-7. Epub 2012 Mar 8. Review.

3.

Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitus.

Yi B, Huang G, Zhou Z.

J Diabetes Investig. 2016 Jul;7(4):459-65. doi: 10.1111/jdi.12441. Epub 2016 Jan 9. Review.

4.

New antigenic targets in type 1 diabetes.

Wenzlau JM, Hutton JC, Davidson HW.

Curr Opin Endocrinol Diabetes Obes. 2008 Aug;15(4):315-20. doi: 10.1097/MED.0b013e328308192b. Review.

PMID:
18594270
5.

Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus.

Yi B, Huang G, Zhou ZG.

Chin Med J (Engl). 2015 Sep 5;128(17):2387-94. doi: 10.4103/0366-6999.163389. Review.

6.

Novel antigens in type 1 diabetes: the importance of ZnT8.

Wenzlau JM, Frisch LM, Gardner TJ, Sarkar S, Hutton JC, Davidson HW.

Curr Diab Rep. 2009 Apr;9(2):105-12. Review.

PMID:
19323954

Supplemental Content

Support Center